Pfizer Deal With Teva Allows For Entry Of Generic Ellence Ahead Of Patent Expiry
This article was originally published in The Pink Sheet Daily
Teva will pay $70 mil. to Pfizer to resolve patent litigation over generic versions of Zithromax and Idamycin.
You may also be interested in...
Company also files patent litigation against generic azithromycin manufacturers Teva and Sandoz.
Teva, Sandoz and Pliva receive FDA clearance for azithromycin; Greenstone launches authorized generic.
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.